Tarsus Pharmaceuticals to present 11 abstracts at American Academy of Optometry annual meeting

By Public Technologies
  • Tarsus Pharmaceuticals to present 11 scientific abstracts at the American Academy of Optometry 2026 Annual Meeting, Sept. 30-Oct. 3, 2026.
  • Sessions scheduled in Anaheim, California, including poster presentations on Oct. 1, 2026, 4:30-6:30 p.m. PDT.
  • One paper presentation set for Oct. 2, 2026, 4:00-4:15 p.m. PDT.
  • Program highlights real-world outcomes with XDEMVY (lotilaner ophthalmic solution) 0.25%, Demodex blepharitis, ocular rosacea.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tarsus Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290830PRIMZONEFULLFEED9835468) on September 29, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk